Nature Biotechnology
16, 29 - 30 (1998)
doi:10.1038/5409
Optimizing the impact of genomics on drug discovery and developmentStanley T. Crooke
Stanley T. Crooke is chairman and CEO of Isis Pharmaceuticals, 2292 Faraday Avenue, Carlsbad, CA 92008. The central challenge is to identify chemicals of sufficient specifity
to exploit molecular biological insights.
|
